Scarica l'app Stockscreener
3.26
9.40%
0.28
Pre-mercato:
3.45
0.19
+5.83%
An 2 Therapeutics Inc Azioni (ANTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
39.14%
10.04
|
7.216 | 11.54 | 8.598 | 14.01 |
| Operating Income/Loss |
39.14%
-10.04
|
-7.216 | -11.54 | -8.598 | -14.01 |
| Income/Loss From Continuing Operations Before Tax |
44.74%
-9.353
|
-6.462 | -10.65 | -7.522 | -12.75 |
| Income/Loss From Continuing Operations After Tax |
44.74%
-9.353
|
-6.462 | -10.65 | -7.522 | -12.75 |
|
Net Income/Loss
|
44.74%
-9.353
|
-6.462 | -10.65 | -7.522 | -12.75 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | 0.001 | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | -0.001 | - |
| Basic Average Shares |
0.34%
30.28
|
30.17 | 30.05 | 0.0184 | 29.84 |
| Diluted Average Shares |
0.34%
30.28
|
30.17 | 30.05 | 0.0184 | 29.84 |
| Basic Earnings Per Share |
47.62%
-0.31
|
-0.21 | -0.35 | -0.25 | -0.43 |
| Diluted Earnings Per Share |
47.62%
-0.31
|
-0.21 | -0.35 | -0.25 | -0.43 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | 0.001 | - |
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):